Search Results - "LULL, JULIA"

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease by Salloway, Stephen, Sperling, Reisa, Fox, Nick C, Blennow, Kaj, Klunk, William, Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S, Porsteinsson, Anton P, Ferris, Steven, Reichert, Marcel, Ketter, Nzeera, Nejadnik, Bijan, Guenzler, Volkmar, Miloslavsky, Maja, Wang, Daniel, Lu, Yuan, Lull, Julia, Tudor, Iulia Cristina, Liu, Enchi, Grundman, Michael, Yuen, Eric, Black, Ronald, Brashear, H. Robert

“…In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes…”
Get full text

Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study by Gopal, Srihari, Hough, David W, Xu, Haiyan, Lull, Julia M, Gassmann-Mayer, Cristiana, Remmerie, Bart M, Eerdekens, Marielle H, Brown, David W

“…This 13-week, double-blind study evaluated the efficacy and safety of the atypical antipsychotic paliperidone palmitate (recently approved in the United…”
Get full text

A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia by PANDINA, Gahan J, LINDENMAYER, Jean-Pierre, LULL, Julia, LIM, Pilar, GOPAL, Srihari, HERBEN, Virginie, KUSUMAKAR, Vivek, YUEN, Eric, PALUMBO, Joseph

“…This study assessed the efficacy and the safety of a dosing regimen that was revised from earlier studies for the investigational injectable atypical…”
Get full text

Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial by Cohen, J A, Cutter, G R, Fischer, J S, Goodman, A D, Heidenreich, F R, Jak, A J, Kniker, J E, Kooijmans, M F, Lull, J M, Sandrock, A W, Simon, J H, Simonian, N A, Whitaker, J N

“…The Multiple Sclerosis Functional Composite (MSFC) is a multidimensional clinical outcome measure that includes quantitative tests of leg function/ambulation…”
Get more information

Effect of bapineuzumab on CSF p-tau and t-tau in mild-to-moderate Alzheimer's disease: Results from two phase III trials in APOE-ε4 carriers and noncarriers by Streffer, Johannes, Blennow, Kaj, Salloway, Stephen, Zetterberg, Henrik, Xu, Yi-Zheng, Lu, Yuan, Lull, Julia, Collins, Peter, Tudor, Iulia Cristina, Gregg, Keith, Styren, Scot, Yuen, Eric, Grundman, Michael, Brashear, Robert H, Liu, Enchi

Get full text

O1–06–02: Effect of bapineuzumab on CSF p‐tau and t‐tau in mild‐to‐moderate Alzheimer's disease: Results from two phase III trials in APOE‐ε4 carriers and noncarriers by Streffer, Johannes, Blennow, Kaj, Salloway, Stephen, Zetterberg, Henrik, Xu, Yi‐Zheng, Lu, Yuan, Lull, Julia, Collins, Peter, Tudor, Iulia Cristina, Gregg, Keith, Styren, Scot, Yuen, Eric, Grundman, Michael, Brashear, Robert H., Liu, Enchi

Get full text

“Summary measure” statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis by SIMONIAN, NANCY A, MCALLISTER, ARTHUR, LULL, JULIA

“…From a clinical perspective, the question should be raised, "Do we want to consider the disability of these patients to be the same by using the AUC summary…”
Get full text

OFF AND RUNNING by Gregory, Sean, Lull, Julia

“…Seun Adigun launched a GoFundMe page last year to help finance an outlandish Olympic pursuit: start a women's bobsled team in Nigeria, a country with a…”
Get full text